AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells
2025 · EMBO Reports · 1 citations
https://doi.org/10.1038/s44319-025-00466-w
H
Hélène Pasquer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
159
Citations
7
h-index
6
i10-index
Hélène Pasquer is an academic researcher from Université Paris Cité. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Nanoparticle-Based Drug Delivery & RNA Interference and Gene Delivery. The author has an h-index of 7, co-authored 52 publications.
ORCID: 0000-0003-1626-0627Papers by this author
worksSupplementary Figure S5 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423524
Supplementary Figure S1 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423536.v1
Supplementary Table 3 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423509
Supplementary Table 2 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423512
Supplementary Figure S1 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423536
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat